Compare RXRX & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXRX | CRGY |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 3.8B |
| IPO Year | 2021 | 2022 |
| Metric | RXRX | CRGY |
|---|---|---|
| Price | $3.78 | $13.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $7.50 | ★ $14.73 |
| AVG Volume (30 Days) | ★ 17.2M | 5.3M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $74,681,000.00 | ★ $3,579,782,000.00 |
| Revenue This Year | $12.11 | $29.70 |
| Revenue Next Year | $82.52 | N/A |
| P/E Ratio | ★ N/A | $99.08 |
| Revenue Growth | ★ 26.92 | 22.14 |
| 52 Week Low | $2.77 | $7.68 |
| 52 Week High | $7.18 | $15.47 |
| Indicator | RXRX | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 46.36 |
| Support Level | $2.90 | $11.45 |
| Resistance Level | $4.03 | $14.06 |
| Average True Range (ATR) | 0.23 | 0.46 |
| MACD | 0.05 | -0.23 |
| Stochastic Oscillator | 64.62 | 10.91 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The company operates in one reportable segment, which is the exploration and production of crude oil, natural gas, and NGLs.